Abstract: A fuel formulation comprising a sugar and ammonia solution, wherein the sugar and ammonia are present in a combined amount of greater than 70 percent by weight of the fuel formulation, and wherein the sugar comprises fructose, glucose, sucrose or a combination thereof.

Abstract: Provided herein are novel pyrazoloquinolinone compounds and method of using such compounds to treat disorders such as neuropsychiatric disorders with sensorimotor gating deficits, such as schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive compulsive disorder, panic disorder, Huntington's disease and nocturnal enuresis; depression; temporomandibular myofascial pain; disorders of trigeminal nerve, such as trigeminal neuralgia and trigeminal neuropathy; migraine; and tinnitus.

Abstract: Measuring an end-to-end delay(s) in a distributed communications system (DCS) is disclosed. The DCS is coupled to a signal source(s) supporting multiple logical channels and includes multiple remote units each communicating in one or more of the logical channels. The DCS is configured to measure an end-to-end delay(s), which includes a path delay(s) between the signal source and the remote units and a local delay(s) at each of the remote units, for each of the logical channels. The measured end-to-end delay(s) can help the signal source to more accurately determine an equivalent coverage range of the DCS, thus making it possible to generate random access preambles for the DCS based on as few Zadoff-Chu (ZC) sequences as possible. By generating the random access preambles based on fewer ZC sequences, it is possible to minimize interference among the random access preambles, thus helping to improve random access performance in the DCS.

Abstract: Excessive deposition of extracellular matrix is a hallmark of Idiopathic pulmonary fibrosis (IPF), it is advantageous to target the cells and the mechanisms associated with this process. By targeting myofibroblasts (specialized contractile fibroblasts) that are key for the development of IPF with drugs conjugated with fibroblast activation protein (FAP), this technology helps minimize the production of extracellular matrix in the lungs and provides a new treatment option for patients diagnosed with IPF.

Abstract: Disclosed herein are a finite-field division operator, an elliptic curve cryptosystem having the finite-field division operator, and a method for operating the elliptic curve cryptosystem. The method for operating an elliptic curve cryptosystem may include, setting, by a key setting unit, a length of a key of a cryptographic algorithm, generating, by the key setting unit, first setup information that indicates a number of words corresponding to the key length, and generating, by the key setting unit, second setup information that indicates a number of repetitions of an operation by a finite-field division operator corresponding to the key length.

Abstract: Disclosed herein are compounds, compositions, and methods of their use for the treatment of diabetes.

Abstract: Various embodiments include an apparatus to supply precursor gases to a processing tool. In various examples, the apparatus includes a point-of-use (POU) valve manifold that includes a manifold body to couple to a processing chamber of the processing tool. The manifold body has a multiple precursor-gas outlet ports surrounded by an annulus. A purge-gas outlet port of the manifold body is directed substantially toward interior walls of the annulus. For each of multiple precursor gases, the POU-valve manifold further includes: a first valve coupled to the manifold body and a divert valve coupled to the first valve. The first valve can be coupled to a precursor-gas supply and has a separate precursor-gas flow path internal to the manifold body. The divert valve diverts the precursor gas during a period when the precursor gas is not to be directed into the processing chamber by the first valve. Other examples are disclosed.

Abstract: The disclosure provides a method and system for implementing inter-process communications. The method includes sending, by a first application, a first message to a forwarding application according to a first preset inter-process communication mode. The first message includes transmission data and identification information of a second application; obtaining, by the forwarding application, the second application in response to the first message; and sending, by the forwarding application, the transmission data to the second application according to a second preset inter-process communication mode of the second application.

Abstract: Provided herein are protein contrast agents and targeted protein contrast agents, formulations thereof, and methods of use, including but not limited to, as a magnetic resonance imaging contrast agent.

Abstract: A system and method of scheduling tasks, comprising receiving activity and performance data from registers or storage locations maintained by hardware and an operating system; storing calibration coefficients associated with the activity and performance data; computing an energy dissipation rate based on at least the activity and performance data; and scheduling tasks under the operating system based on the computed energy dissipation rate.

Abstract: The present invention relates to an oral formulation containing one or more cannabinoids. Preferably one or more cannabinoids dissolved in a solvent system consisting essentially of: a non-ionic surfactant and water together with other components which ensure the cannabinoids stability and the formulations palatability. Furthermore, the cannabinoid may be selected from one or more of cannabichromene (CBC), cannabichromenic acid (CBCV), cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabigerol (CBG), cannabigerol propyl variant (CBGV), cannabicyclol (CBL), cannabinol (CBN), cannabinol propyl variant (CBNV), cannabitriol (CBO), tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV) and tetrahydrocannabivarinic acid (THCVA).

Abstract: A wavelength multiplexing device is disclosed. When light is irradiated on a first longitudinal end region of a metal nano-structure, surface plasmon polaritons are generated in the first longitudinal end region. The surface plasmon polaritons and the light are coupled with each other to form first coupled surface plasmon polaritons, wherein the first coupled surface plasmon polaritons propagate along and on a surface of the metal nano-structure. When the first coupled surface plasmon polaritons reach a two-dimensional material layer, excitons are induced in the two-dimensional material layer, wherein the induced excitons and the first coupled surface plasmon polaritons are coupled with each other to form second coupled surface plasmon polaritons. The second coupled surface plasmon polaritons propagate along and on a surface of the metal nano-structure toward a second longitudinal end thereof.

Abstract: A method for calibration, in a serial fronthaul in which a calibration device and L (L is a natural number equal to or greater than 1) access node(s) (AN(s)) are serially connected, may include: transmitting, by the calibration device, to at least part of the L AN(s), a calibration command message indicating calibration of transmission paths; determining, by the calibration device and the at least part of the L AN(s), time delay values and phase characteristic values of the transmission paths of the at least part of the L AN(s); and transmitting, by the calibration device, to the at least part of the L AN(s), a calibration adjustment message indicating calibration of the transmission paths based on the time delay values and the phase characteristic values of the transmission paths of the at least part of the L AN(s).

Abstract: A multi-access edge computing device configured to be connected to first and second networks with different radio access technologies comprises a routing module, a comparison module and a control module. The control module performs steps when determining a user device connected to the first network intends to switch to the second network, wherein the steps comprise: according to identity information of the user device, looking up a target address in a comparison table in the comparison module, notifying the routing module to temporarily store a data packet corresponding to the user device and the first network, notifying the user device to release an original used address on the first network interface and then assigning the target address identical to the original used address to the second network interface of the user device, and transmitting the temporarily stored data packet to the second network interface of the user device.

Abstract: A semiconductor component is disclosed. The semiconductor component can include: a semiconductor layer injected with a same type of dopant; a gate electrode formed above the semiconductor layer with a gate insulation film positioned in-between; a dielectric layer formed on the semiconductor layer at both sides of the gate electrode; and source/drain electrodes each formed on the dielectric layer.

Abstract: This document provides methods and materials related to using monovalent anti-CD3 antibodies (e.g., monovalent anti-CD3 Fab fragments) as adjuvants to increase the immune response produced against an antigen (e.g., a tumor associated antigen). For example, vaccine compositions containing monovalent anti-CD3?? Fab fragments in combination with tumor associated antigens (e.g., tumor associated antigens having little or no immunogenicity in the absence of monovalent anti-CD3?? Fab fragments) alone or in combination with adjuvants for signals two and/or three required for full activation of T cell immune function, as well as methods and materials for using monovalent anti-CD3?? Fab fragments to increase the immune response produced against an antigen (e.g., a tumor associated antigen) within a mammal (e.g., a human) are provided.

Abstract: A three-dimensional (3D) printing methodology is disclosed for freeform fabrication of hydrophobic structures without the use of printed support structures. The build material is directly printed in and supported by a fumed silica-containing yield-stress support bath to form an intermediate article in the support bath material. The intermediate article may be liquid or only partially solidified after being printed into the support bath material. The intermediate article is then heated or irradiated with ultraviolet radiation to initiate cross-linking to solidify the printed intermediate article, forming a finished article.

Abstract: Provided herein are methods of inhibiting the aggregation of asphaltenes, as well as methods of identifying appropriate aggregation inhibitors for asphaltenes.

Abstract: A method for training a computerized mechanical device, comprising: receiving data documenting actions of an actuator performing a task in a plurality of iterations; calculating using the data a neural network dataset and used for performing the task; gathering in a plurality of reward iterations a plurality of scores given by an instructor to a plurality of states, each comprising at least one sensor value, while a robotic actuator performs the task according to the neural network; calculating using the plurality of scores a reward dataset used for computing a reward function; updating at least some of the neural network's plurality of parameters by receiving in each of a plurality of policy iterations a reward value computed by applying the reward function to another state comprising at least one sensor value, while the robotic actuator performs the task according to the neural network; and outputting the updated neural network.

Abstract: In the present system and method, a conduit from a LC device continuously transports solvent, buffers, and analytes to the inlet of a solvent removal and analyte conversion device which evaporates the solvents, leaving non-volatile analytes for detection. The device comprises a rotating disk. The liquid chromatograph device can be any device using liquid chromatography to separate molecules. The solvents in the LC effluent can include, but are not limited to, water, methanol, acetonitrile, tetrahydrofuran, and acetone. After removal of the volatile components, the non-volatile analytes are converted with a concentrated energy source so that they may be detectable.